Nurix Therapeutics
NRIX
NRIX
113 hedge funds and large institutions have $1.18B invested in Nurix Therapeutics in 2021 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 33 increasing their positions, 32 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
113
Holders Change
+10
Holders Change %
+9.71%
% of All Funds
1.98%
Holding in Top 10
9
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+28.57%
% of All Funds
0.16%
New
26
Increased
33
Reduced
32
Closed
15
Calls
$204K
Puts
$13K
Net Calls
+$191K
Net Calls Change
+$204K
Top Buyers
| 1 |
1
T. Rowe Price Associates
Baltimore,
Maryland
|
$141M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$59.3M |
| 3 |
3
BlackRock
New York
|
$74.4M |
| 4 |
CCP
4
Clough Capital Partners
Boston,
Massachusetts
|
$14.2M |
| 5 |
O
5
OrbiMed
New York
|
$17.3M |
